Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from IM Cannabis

IM Cannabis Revenue Grows 78% YoY, What About Debt?

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) Q3 2022 revenues were CA$14.2 million ($10.7 million), compared to CA$8.0 million on Q3 2021, an increase of 78%, representing a 12% sequential organic growth.

Benzinga · Nov 14, 2022

IM Cannabis Q2 Revenue Grows 114% YoY, What About Profit?

IM Cannabis Corp. (NASDAQ: IMCC) (CSE:IMCC) released financial results for its second quarter ended June 30, 2022, revealing revenues increased 114% year-over-year to CA$23.8 million ($18.43 million). Q2 2022 Financial Results

Benzinga · Aug 15, 2022

Hamburg Launched Partnership To Ease the Burden On Medical Marijuana Patients And Doctors

By Oren Shuster The project, known as “Pain Initiative Cannabinoids 2021”, is a crucial development in advancing the German cannabis industry

Benzinga · Jul 13, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

EXCLUSIVE: International Cannabis Companies Share Solutions For Global Expansion

As the business of cannabis grows in size and opportunity, many companies in the space are wondering about the challenges of international expansion.

Benzinga · Apr 20, 2022

IM Cannabis Revenue In 2021 Grows 242% to $43.38M

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) released financial results for the three months and fiscal year ended December 31, 2021.

Benzinga · Mar 31, 2022

IM Cannabis Closes Acquisition Of Israel's Medical Marijuana Oranim Pharm

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) has completed the strategic acquisition of 51% of the rights in Oranim Pharm partnership, a pharmacy selling medical cannabis in Israel. The acquisition was completed through IMC Holdings Ltd., a wholly-owned subsidiary of IM Cannabis Corp., following receipt of all requisite approvals, including from the Israeli Medical…

Benzinga · Mar 30, 2022

IM Cannabis Closes Three Strategic Acquisitions In Israel Valued Around $11.77M

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) has completed three strategic acquisitions.

Benzinga · Mar 15, 2022

Read news from The Economist, FT, and more,
with one subscription

IM Cannabis Q4 Revenues To Increase 308% YoY, Positioned To Capture Market Growth In Israel

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) has reported its preliminary unaudited financial results for the three months and fiscal year ended December 31, 2021.

Benzinga · Mar 10, 2022

IM Cannabis Taps MZ Group To Lead Strategic Investor Relations & Shareholder Communications Program

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) has engaged international investor relations specialists MZ Group to lead the Company's strategic investor relations and financial communications program across all key markets.

Benzinga · Feb 8, 2022

IM Cannabis Imports 400 Kilos Of Premium Indoor-Grown Dried Cannabis From Canada To Israel

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) announced on Wednesday that Focus Medical Herbs Ltd.

Benzinga · Jan 19, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Marijuana

2,241 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.